← Leaderboards
Michael Petrascheck
Scripps Research Institute, The
$13,347,538
Attributed
$16,986,265
Total exposure
11
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $4M · FY2011–25$5M$3.8M$2.5M$1.3M$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$16,986,265 · 11
By mechanism
R01$11,709,802 · 6
DP2$2,842,500 · 1
R21$1,562,000 · 3
R56$871,963 · 1
Top collaborators
- Olivia D Osborn5 shared
- Sandra E Encalada2 shared
- Kristin Kay Baldwin1 shared
- Anton Maximov1 shared
- John Robert Yates1 shared
Most similar at Scripps Research Institute, The
Same institution · by research overlap
- Sandra E Encalada$6,652,685
- Peter Edwin Wright$37,349,507
Others in their field
Top investigators on “Alzheimer&Apos”
- Jose A Luchsinger · Columbia University Health Sciences$56,595,040
- Eric M Reiman · Banner Health$48,982,487
- Yadong Huang · J. David Gladstone Institutes$40,311,515
- Lindsay A. Farrer · Boston University Medical Campus$34,189,802
- David M Holtzman · Washington University$28,985,806
- Michael W Weiner · Northern California Institute Res &Educ$28,197,224
Research focus
Alzheimer&AposPreventCaenorhabditis ElegansGene ExpressionResponsePhenotypeToxic EffectPharmaceutical PreparationsGenesS DiseasePathway InteractionsAgingLinkNeuronsAnimalsMitochondriaCellsBaseBrainEnergy MetabolismS Disease Related DementiaInsightEatingLongevity
Grant awards (23)
Cell Specific Perturbations of the Proteome in Alzheimer's Disease$1,338,900
R01 · FY2025 · AG
Restoring neuronal degradative capacity as a therapeutic strategy to treat Prion Disease$909,090
R01 · FY2025 · NS
A druggable mito-nuclear feedback mechanism that preserves mitochondrial and synaptic function in old-age$878,190
R01 · FY2025 · AG · contact PI
Contributions of cell type and exosome signaling to prodromal synaptic and circuit changes in Alzheimer's Disease models$848,559
R01 · FY2025 · AG · contact PI
Lowering Mitochondrial ATP Synthase Activity Slows Aging and Alzheimer's Disease$910,978
R01 · FY2024 · AG · contact PI
Lifespan extension by reverse fasting$226,250
R21 · FY2024 · AG · contact PI
Lowering Mitochondrial ATP Synthase Activity Slows Aging and Alzheimer's Disease$910,978
R01 · FY2023 · AG · contact PI
Activation of Neuronal Degradative Pathways to Ameliorate Prion Disease$871,963
R56 · FY2023 · NS
Lifespan extension by reverse fasting$271,500
R21 · FY2023 · AG · contact PI
Lowering Mitochondrial ATP Synthase Activity Slows Aging and Alzheimer's Disease$898,273
R01 · FY2022 · AG · contact PI
An in vivo screening system for chemical modulators of eating behavior$541,337
R01 · FY2022 · DK · contact PI
Lowering Mitochondrial ATP Synthase Activity Slows Aging and Alzheimer's Disease$336,270
R01 · FY2022 · AG · contact PI
Lowering Mitochondrial ATP Synthase Activity Slows Aging and Alzheimer's Disease$898,273
R01 · FY2021 · AG · contact PI
An in vivo screening system for chemical modulators of eating behavior$539,778
R01 · FY2021 · DK · contact PI
Epoxide metabolism as a modulator of aging$241,875
R21 · FY2021 · AG · contact PI
Lowering Mitochondrial ATP Synthase Activity Slows Aging and Alzheimer's Disease$917,648
R01 · FY2020 · AG · contact PI
An in vivo screening system for chemical modulators of eating behavior$561,692
R01 · FY2020 · DK · contact PI
Epoxide metabolism as a modulator of aging$290,250
R21 · FY2020 · AG · contact PI
An in vivo screening system for chemical modulators of eating behavior$594,335
R01 · FY2019 · DK · contact PI
Mechanisms of mRNA translation that modulate protein aggregation$241,875
R21 · FY2019 · NS · contact PI
An in vivo screening system for chemical modulators of eating behavior$625,501
R01 · FY2018 · DK · contact PI
Mechanisms of mRNA translation that modulate protein aggregation$290,250
R21 · FY2018 · NS · contact PI
Modulation of Sensory Perception to Treat Age Related Disease$2,842,500
DP2 · FY2011 · OD · contact PI